Skip to content

Efficacy of a sexual quality of life intervention for couples facing metastatic breast cancer: Results of a randomized controlled trial.

·

AI-generated research brief — verify at source

Couple-Based Video Intervention Improves Sexual Quality of Life in Metastatic Breast Cancer

A randomized controlled trial found that a four-session videoconference intervention for couples affected by metastatic breast cancer produced statistically significant and durable improvements in patients’ sexual function, desire, distress, and satisfaction compared to an informational booklet, with benefits persisting at six-month follow-up. Partner outcomes, including sexual distress, self-efficacy, communication, and relationship intimacy, also improved meaningfully, underscoring the value of a dyadic approach in this historically underserved population.

What Was Studied

This trial investigated whether a structured, couple-focused intervention could meaningfully improve sexual quality of life for women living with metastatic breast cancer and their intimate partners. Sexual concerns are common and often severe in this population, yet evidence-based interventions specifically adapted for metastatic disease—rather than early-stage cancer survivorship—have been largely absent from the literature.

How It Was Studied

Fifty-five female patients with metastatic breast cancer who reported sexual concerns, along with their intimate partners, were enrolled for a total of 110 participants. Couples were randomly assigned to either the Adapted Intimacy Enhancement (AIE) program—a four-session videoconference intervention delivering education and skills training for managing sexual and intimacy concerns—or to Enhanced Care-As-Usual (ECAU), which consisted of a detailed informational booklet on sex and intimacy. Outcomes were assessed at three time points: baseline, immediately post-intervention, and at a six-month follow-up. Primary outcomes focused on patients’ sexual function, sexual distress, and sexual self-efficacy, while secondary outcomes captured sexual communication, relationship intimacy, and psychological distress for both patients and partners. Intervention effects were estimated using mixed linear regression models, with dyadic analyses applied to psychosocial outcomes and Cohen’s d used to quantify effect sizes.

What Was Observed

  • Patients receiving AIE showed significantly greater improvements in overall sexual function, desire, and sexual distress at six months compared to ECAU—differences that were statistically reliable (overall function p = .018; desire p = .007; distress p = .046). These gains suggest the intervention moved beyond symptom awareness to produce measurable functional change.
  • Patient sexual satisfaction improved in the AIE group at both post-intervention and six-month assessments, with the six-month effect reaching a high level of statistical confidence (p < .001). The trial authors identified patient sexual satisfaction as showing the largest effect size across all patient outcomes.
  • Partners randomized to AIE reported significant improvements in sexual distress, sexual self-efficacy, sexual communication, and relationship intimacy at six months (p values ranging from .004 to .01). Partner sexual distress showed the largest effect size among partner outcomes, suggesting the intervention meaningfully reduced the burden borne by caregiving partners.
  • No statistically significant advantage was observed for AIE on patient sexual self-efficacy or several psychosocial outcomes at the earlier post-intervention time point, indicating that some benefits may require time to consolidate and are better captured at longer follow-up.

Why This Matters

Metastatic breast cancer is increasingly a chronic illness, yet sexual health interventions have predominantly been developed and tested in early-stage survivors whose disease trajectory and concerns differ considerably. This trial provides rare evidence that a relatively brief, remotely delivered, couple-based program can generate durable improvements in both patient and partner sexual well-being, extending the scope of psychosocial oncology beyond individual patients. The dyadic findings are particularly notable because they suggest that partners experience their own distinct sexual burden that responds to targeted support.

How to Read This Result

With only 55 couples enrolled, the trial was modestly powered, and the generalizability of these findings to more diverse MBC populations—including those with varying disease burden, treatment status, or relationship structures—remains to be established in larger, more representative samples.

Limitations

The abstract does not explicitly report study limitations beyond the implicit constraint of sample size and the authors’ call for future research to identify intervention mediators and optimal dissemination strategies.

Randomized Controlled Trial
Source
Cancer· PMID: 41722045
View full study
Disclaimer: Content on MEDITELI is AI-generated for informational purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before making health-related decisions. Original research should be reviewed in full before clinical application.